Medical Products Regulation (MPR) Symposium

Medical Products Regulation (MPR) Symposium

The MPR Symposium is a flagship event co-organized by the Department of Health (DH) and HKSTP.

“The Chief Executive’s 2023 Policy Address” announced that the Government will leverage the medical strengths of the Hong Kong Special Administrative Region with the long-term objective of establishing an authority. Hong Kong Preparatory Office for the Centre for Medical Products Regulation (CMPR) was set up under DH in June 2024, tasked with transforming Hong Kong into a global hub for health and medical innovation. CMPR’s specific functions include:   registration of drugs and medical devices (medical products) under the “primary evaluation” approach, direct approvalfor registration of medical products in Hong Kong based on clinical trial data, without relying on registration approval from other drug regulatory authorities. This will help accelerate the clinical use of new drugs and medical devices, and foster the development of industries relating to the research and development and clinical trials of medical products, developing Hong Kong into an international health and medical innovative hub.

The MPR Symposium will explore key developments in medical product (registered drugs and medical devices) regulation and innovation, featuring insights into upcoming regulatory frameworks, Hong Kong’s evolving health technology ecosystem, and advancements in clinical trials. The symposium will feature a conference as well as tech showcase during networking/break session.

Admission is free, but registration is required